News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
10,146 Results
Type
Article (328)
Press Release (9818)
Section
Business (2607)
Deals (450)
Drug Delivery (1)
Drug Development (2489)
FDA (396)
Job Trends (370)
News (5844)
Policy (463)
Tag
Academia (26)
Allergies (1)
Alliances (552)
Alzheimer's disease (6)
Antibody-drug conjugate (ADC) (2)
Approvals (401)
Bankruptcy (3)
Best Places to Work (381)
Bladder cancer (4)
Breast cancer (3)
Cancer (36)
Cardiovascular disease (2)
Cell therapy (8)
Clinical research (2175)
Collaboration (13)
Compensation (7)
COVID-19 (9)
CRISPR (1)
C-suite (5)
Data (69)
Diabetes (5)
Diagnostics (27)
Earnings (1161)
Events (1619)
Executive appointments (10)
FDA (424)
Funding (6)
Gene editing (2)
Gene therapy (14)
GLP-1 (8)
Government (54)
Grass and pollen (1)
Healthcare (267)
Infectious disease (10)
Influenza (1)
IPO (257)
Job creations (20)
Layoffs (5)
Legal (34)
Liver cancer (3)
Lung cancer (13)
Medical device (173)
Medtech (173)
Mergers & acquisitions (204)
Metabolic disorders (6)
Multiple sclerosis (1)
Neuroscience (7)
NextGen: Class of 2025 (55)
Non-profit (16)
Northern California (29)
Ovarian cancer (4)
Pain (6)
Patents (3)
Patient recruitment (5)
People (821)
Phase I (498)
Phase II (970)
Phase III (898)
Pipeline (20)
Postmarket research (60)
Preclinical (184)
Radiopharmaceuticals (4)
Real estate (22)
Regulatory (425)
Research institute (20)
Series A (1)
Series B (1)
Southern California (33)
Startups (60)
United States (345)
Vaccines (5)
Weight loss (1)
Date
Today (2)
Last 7 days (10)
Last 30 days (37)
Last 365 days (836)
2025 (30)
2024 (853)
2023 (974)
2022 (1129)
2021 (1264)
2020 (941)
2019 (686)
2018 (516)
2017 (557)
2016 (497)
2015 (586)
2014 (379)
2013 (223)
2012 (204)
2011 (221)
2010 (238)
Location
Africa (2)
Asia (479)
Australia (74)
California (73)
Canada (11)
China (4)
Delaware (6)
Europe (1336)
Florida (3)
Georgia (13)
Idaho (5)
Illinois (6)
Indiana (2)
Japan (3)
Maryland (11)
Massachusetts (93)
Michigan (5)
New Jersey (35)
New York (29)
North Carolina (22)
Northern California (29)
Ohio (2)
Pennsylvania (21)
South America (5)
Southern California (33)
Tennessee (4)
Texas (9)
Washington State (10)
10,146 Results for "ocular therapeutix".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ocular Therapeutix™ Shares SOL-R Enrollment Progress and Next Steps for AXPAXLI™ in NPDR
January 14, 2025
·
13 min read
Genetown
Ocular Therapeutix® to Host Investor Day on June 13, 2024
Ocular Therapeutix, Inc. will host an Investor Day on Thursday, June 13, 2024.
June 5, 2024
·
5 min read
Press Releases
Ocular Therapeutix™ to Participate in December Investor and Scientific Conferences
November 26, 2024
·
2 min read
Press Releases
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - January 17, 2025
January 20, 2025
·
2 min read
Press Releases
Ocular Therapeutix™ to Provide Corporate Update During 43rd Annual J.P. Morgan Healthcare Conference Presentation
January 8, 2025
·
2 min read
Press Releases
Ocular Therapeutix™ to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 10, 2024
·
1 min read
Press Releases
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 13, 2024
·
2 min read
Press Releases
Ocular Therapeutix™ Announces More Than 300 Subjects Randomized in SOL-1
December 2, 2024
·
11 min read
Press Releases
Ocular Therapeutix™ to Present at October Ophthalmology Meetings
October 9, 2024
·
2 min read
Press Releases
Ocular Therapeutix™ Reports Third Quarter 2024 Results and Business Highlights
November 15, 2024
·
17 min read
1 of 1,015
Next
